Cooper Cos. (COO) Tops Q3 EPS by 7c; Guides Q4, Raises FY11 Outlook
Get Alerts COO Hot Sheet
Price: $65.94 +0.79%
EPS Growth %: +1.8%
Financial Fact:
Research and development expense: 16.01M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +1.8%
Financial Fact:
Research and development expense: 16.01M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Cooper Cos. (NYSE: COO) reported Q3 EPS of $1.15, $0.07 better than the analyst estimate of $1.08. Revenue for the quarter came in at $351.4 million versus the consensus estimate of $331.82 million.
Cooper Cos. sees Q4 2011 EPS of $1.19-$1.24, versus the consensus of $1.19. Cooper Cos. sees Q4 2011 revenue of $350-$365 million, versus the consensus of $346.1 million.
Cooper Cos. sees FY2011 EPS of $4.20-$4.25, versus prior guidance of $4.00-$4.15 and the consensus of $4.12. Cooper Cos. sees FY2011 revenue of $1.32-$1.335 billion, versus prior guidance of $1.28-$1.3 billion and the consensus of $1.29 billion.
Cooper Cos. sees Q4 2011 EPS of $1.19-$1.24, versus the consensus of $1.19. Cooper Cos. sees Q4 2011 revenue of $350-$365 million, versus the consensus of $346.1 million.
Cooper Cos. sees FY2011 EPS of $4.20-$4.25, versus prior guidance of $4.00-$4.15 and the consensus of $4.12. Cooper Cos. sees FY2011 revenue of $1.32-$1.335 billion, versus prior guidance of $1.28-$1.3 billion and the consensus of $1.29 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- CarMax beats estimates as new strategy drives early results
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share